Clinical Trials

Cirrhosis, Familial, with Pulmonary Hypertension, Liver Neoplasms, Recurrence, Cholangiocarcinoma

NCT07225452 2026-03-13

LUMIC

Completed

535 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Liver Neoplasms, Cholangiocarcinoma

NCT06859684 2026-03-09

HAIC-quad

25 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06739252 2026-01-28

Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

Phase 2 Terminated

1 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma, Klatskin Tumor

NCT07353827 2026-01-20

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

36 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07337850 2026-01-13

FAPi-2

Recruiting

60 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT07304388 2025-12-30

HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC

Phase 2 Completed

96 enrolled

EndocrineGastrointestinalNET

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06735560 2025-12-08

ELEGANCE

Phase NA Recruiting

60 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Carcinoma, Hepatocellular, Cholangiocarcinoma, Neuroendocrine Tumors

NCT06925516 2025-11-28

ACADEMY

38 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07153783 2025-11-18

Interventional AI-Human Collaboration for Liver Tumor Diagnosis

Phase NA Completed

10,333 enrolled

Phase NA Not yet recruiting

Cirrhosis, Familial, with Pulmonary Hypertension, Cysts, Carcinoma, Hepatocellular, Cholangiocarcinoma, Focal Nodular Hyperplasia

NCT07208526 2025-10-06

A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST

270 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07176962 2025-09-16

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

Recruiting

1,800 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Disease, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT07161869 2025-09-09

POELH-III

Not yet recruiting

250 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Biliary Tract Neoplasms, Common Bile Duct Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT07128290 2025-08-17

PEHRICCA

49 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07070700 2025-08-12

CASTLE-ZS-02

56 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07043348 2025-07-20

ISTAR-04

Terminated

1 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07063888 2025-07-14

A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma

66 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06946849 2025-04-27

SED-RO-ICC

76 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06888063 2025-03-21

PUMP IV

40 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06862934 2025-03-06

iCOLA

Recruiting

14 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06721286 2024-12-06

Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma

70 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06648525 2024-10-18

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

68 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT01917370 2013-08-06

icc

Unknown

20 enrolled